Focus on Detecting Extractables and Leachables in Drug Products to Improve Patient Safety and Avoid Costly Product-launch Delays

Well-documented incidents of contaminants leaching from containers and packaging has brought heightened awareness of the health risks posed by extractables and leachables in the manufacture of pharmaceutical container systems and product packaging. In fact, the U.S. FDA and the EMEA are now placing increased scrutiny on potential extractables and leachables in drug product container and closure systems.

Enter your details below to view the free whitepaper

By downloading this Whitepaper, you acknowledge that Global Data Plc may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Global Data Plc may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.